SHINE has established one of the most commercially credible pathways in the fusion sector by building revenue-driving businesses around fusion-driven neutron production, isotope manufacturing, and waste recycling. 

• How is SHINE’s staged model reshaping expectations for valuation, commercialization timelines, and investor confidence?
• Does SHINE’s staged commercialization model translate into a differentiated and compelling investment proposition? How do investors compare SHINE’s risk profile and valuation against traditional fusion companies?
• What are the key milestones - and how well is SHINE tracking toward them?

A candid, fireside chat with: